Filing Details

Accession Number:
0001179110-18-002111
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-02-14 18:11:08
Reporting Period:
2018-02-12
Accepted Time:
2018-02-14 18:11:08
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1235010 Momenta Pharmaceuticals Inc MNTA Biological Products, (No Disgnostic Substances) (2836) 043561634
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1294284 Venkataraman Ganesh Kaundinya C/O Momenta Pharmaceuticals, Inc.
675 West Kendall Street
Cambridge MA 02142
Coo & Cso No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-02-12 10,103 $7.41 501,031 No 4 M Direct
Common Stock Disposition 2018-02-12 341 $16.20 500,690 No 4 S Direct
Common Stock Disposition 2018-02-14 4,645 $15.16 496,045 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Units Disposition 2018-02-12 50,000 $0.00 50,000 $0.00
Common Stock Stock Option (Right to Buy) Acquisiton 2018-02-12 10,103 $7.41 10,103 $7.41
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
50,000 No 4 A Direct
0 2012-02-22 2018-02-22 No 4 M Direct
Footnotes
  1. This transaction was effected pursuant to a Rule 10b5-1 trading plan.
  2. Each Restricted Stock Unit represents a contingent right to receive one share of MNTA common stock.
  3. Subject to certain criteria, the restricted stock units will vest with respect to 50% of the shares on the first anniversary of the grant date, and the remaining 50% will vest on the second anniversary of the grant date.